# Fecal Microbiota Transplantation in Depression

> **NCT03281044** · PHASE2 · TERMINATED · sponsor: **Psychiatric Hospital of the University of Basel** · enrollment: 4 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Fecal microbiota capsules
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03281044
- **Lead sponsor:** Psychiatric Hospital of the University of Basel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-24
- **Primary completion:** 2020-03-16
- **Final completion:** 2020-03-16
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Although not observed in our patients (4 enrolled), SAEs have been reported in other patients receiving the same product.
- **Last updated:** 2020-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03281044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03281044, "Fecal Microbiota Transplantation in Depression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03281044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*